The novel therapy of this peptide represents a major development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – https://tirzepatide-peptide754381.ttblogs.com/22025764/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment